Novo Nordisk
E455777
Novo Nordisk is a global healthcare company based in Denmark, best known as a leading producer of insulin and other diabetes care treatments.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Novo Nordisk canonical | 4 |
| Novo Nordisk global corporate structure | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4649558 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Novo Nordisk Context triple: [Nasdaq Copenhagen, listedCompany, Novo Nordisk]
-
A.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
B.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
C.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
-
D.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
E.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Novo Nordisk Target entity description: Novo Nordisk is a global healthcare company based in Denmark, best known as a leading producer of insulin and other diabetes care treatments.
-
A.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
B.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
C.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
-
D.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
E.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
Biotechnology company
ⓘ
Pharmaceutical company ⓘ Public company ⓘ |
| country | Denmark ⓘ |
| focusesOn |
Chronic disease management
ⓘ
Metabolic disorders ⓘ |
| formedByMergerOf |
Nordisk Gentofte
NERFINISHED
ⓘ
Novo Industri NERFINISHED ⓘ |
| foundedBy |
August Krogh
NERFINISHED
ⓘ
Hans Christian Hagedorn NERFINISHED ⓘ Marie Krogh NERFINISHED ⓘ |
| hasDivision |
Diabetes and Obesity Care
NERFINISHED
ⓘ
Rare Disease ⓘ |
| hasParentOrganization | Novo Holdings NERFINISHED ⓘ |
| hasSubsidiary | Novo Nordisk Inc. NERFINISHED ⓘ |
| headquartersLocation | Bagsværd, Denmark NERFINISHED ⓘ |
| inception | 1923 ⓘ |
| industry |
Biotechnology industry
ⓘ
Healthcare ⓘ Pharmaceutical industry ⓘ |
| legalForm | Aktieselskab ⓘ |
| listedOn | New York Stock Exchange ⓘ |
| majorProduct |
Levemir
NERFINISHED
ⓘ
NovoRapid ⓘ Ozempic NERFINISHED ⓘ Rybelsus NERFINISHED ⓘ Saxenda NERFINISHED ⓘ Tresiba NERFINISHED ⓘ Victoza NERFINISHED ⓘ Wegovy NERFINISHED ⓘ |
| memberOf |
EFPIA
NERFINISHED
ⓘ
International Diabetes Federation corporate partners ⓘ |
| numberOfEmployees | over 50,000 ⓘ |
| operatesIn |
Africa
ⓘ
Asia ⓘ Europe ⓘ Latin America ⓘ North America ⓘ |
| researchFocus |
GLP-1 receptor agonists
NERFINISHED
ⓘ
Insulin analogues ⓘ Obesity pharmacotherapy ⓘ |
| specializesIn |
Diabetes care
ⓘ
Growth hormone therapy ⓘ Haemophilia treatment ⓘ Insulin production ⓘ Obesity care ⓘ |
| stockExchange | Nasdaq Copenhagen NERFINISHED ⓘ |
| tickerSymbol |
NOVO-B
NERFINISHED
ⓘ
NVO NERFINISHED ⓘ |
| website | https://www.novonordisk.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Novo Nordisk Description of subject: Novo Nordisk is a global healthcare company based in Denmark, best known as a leading producer of insulin and other diabetes care treatments.
Referenced by (5)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Novo Nordisk global corporate structure